What is AbCellera Biologics Inc.'s number of joint ventures?

AbCellera Biologics Inc. (ABCL) reported number of joint ventures of 2 in Q1 2026.

What does number of joint ventures mean?

The total count of collaborative business arrangements where the company shares control and economic interests with another entity. This metric tracks the company's reliance on external partnerships for research or commercialization efforts.

AbCellera Biologics Inc. ABCL Number of joint ventures

Number of joint ventures at other companies

HubbellHUBB

20.0%

FlowserveFLS

10.0%

FlowserveFLS

10.0%

Public StoragePSA

$383.92M+2.6%

M/I HomesMHO

$0—

EPR PropertiesEPR

$12.32M-12.1%

Other financials

Income statement

See full

Revenue$8.3M+96.3%

Operating income-$57.5M+8.2%

Net income-$43.2M+5.4%

EPS (diluted)-$0.14+6.7%

Balance sheet

See full

Cash & equivalents$102.1M-44.6%

Total debt$140.2M+107%

Total equity$938.1M-8.3%

Total assets$1.3B-2.8%

Cash flow

See full

Operating cash flow-$33.5M-190%

CapEx$3.8M-64.0%

Free cash flow-$37.4M-68.3%

Valuation

See full

Market cap$2.03B+99.8%

Enterprise value$2.07B+130%

P/S25.7×-18.4×

Profitability

See full

Operating margin-267.6%-120pp

Net margin-181.7%-77.9pp

FCF margin-238.9%-90.9pp

Returns & leverage

See full

Return on equity-14.7%-0.8pp

Debt / equity0.1×+0.1×

Current ratio14.1×+3.9×

Where this comes from

Reported directly by AbCellera Biologics Inc. in its filing.

Tagged under the XBRL concept abcl:NumberOfJointVentures.

The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about AbCellera Biologics Inc.'s number of joint ventures.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AbCellera Biologics Inc.'s number of joint ventures?: AbCellera Biologics Inc. (ABCL) reported number of joint ventures of 2 in Q1 2026.
What does number of joint ventures mean?: The total count of collaborative business arrangements where the company shares control and economic interests with another entity. This metric tracks the company's reliance on external partnerships for research or commercialization efforts.